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Objective:  To determine the frequency, pattern and outcome of early complications after endoscopic third 
ventriculostomy (ETV) in Obstructive hydrocephalus. 
Material and Methods:  The study included 160 patients from Neurosurgery department, Lady Reading Hospital 
Peshawar and private clinics over a period of twelve months. After performing ETV under general anesthesia by 
a single expert neurosurgeon, the patients were followed up for seven days post operatively for the CSF leak, 
wound infection, meningitis, seizures, bleeding and in hospital death. 
Results:  Eighty five percent of the patients had no untoward complications, while 15% showed complications 
including CSF leak (5%), wound infection (3%), meningitis (2%), seizures (2%), bleeding (2%) and in hospital 
death (1%). 
Conclusion:  Due to the less invasive nature, endoscopic third ventriculostomy is favored for treating obstructive 
hydrocephalus in select patient population as it is safe and have better outcomes. 
Keywords:  Endoscopic third ventriculostomy, Obstructive hydrocephalus, CSF leak, Complications. 




The development of unidirectional valve systems, 
connected to biocompatible silicon catheters, the 
ventriculo-artrial and ventriculo-peritoneal shunts 
remained first line treatment options for the 
management of all types of hydrocephalus for over 40 
years.1 The technical developments on the valves, led 
to the creation of autoregulating, antisiphon, externally 
adjustable and gravitational valves.2 The aim of these 
developments was to assure continuous and stable 
flow independent of the horizontal or upright position 
of the patient and the individually required pressure to 
reduce the hydrocephalus and evading the over 
drainage. These means are helpful to avoid the risk of 
hydraulic mismanagements leading to over or 
underdrainage but the major problems associated with 
the shunt implantation persist i.e., shunt infection and 
shunt dysfunction.2,3 
 These two complications led the neurosurgeons to 
search new modalities to manage obstructive 
hydrocephalus. One such possible alternative for shunt 
implantation was the inner shunting by puncturing 
floor of the third ventricle and communicating with the 
basal cisterns. Walter Dandy4 in 1922 used 
ventriculostomy to visualize the ventricles using 
subfrontal approach and then modified it to the lateral 
subtemporal route. Stookey and Scarff further 
improved this technique by puncturing lamina 
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terminalis and third ventricular floor from subfrontal 
approach.5 For the first time, Mixter was the one who 
used an endoscope for making the stoma in the floor of 
the third ventricle through the transventricular 
approach.6 ETV has been revolutionized the treatment 
of obstructive hydrocephalus with enhancement of the 
tools, especially working channels within the 
endoscopic sheath, and also optic quality 
improvements play a pivotal role in this aspect.7,8 
Obstructive hydrocephalus could be safely and 
effectively treated by ETV, which is to make stoma in 
floor of the third ventricle, results in communicating 
third ventricle with the basal cisterns, hence allowing 
free CSF flow.9 McNickle in 1947, described 
Ventriculostomy as “an attempt to bypass 
obstruction”.10 
 In the literature the complication rate for the ETV 
ranges between 2 – 15%, having very rarely permanent 
debilitating complications. Having said that, 
complications like gaze palsy, fever, altered 
consciousness, diabetes insipidus, precocious puberty, 
hemiparesis, memory disorders, weight gain and 
bleeding have been reported.11-13 Other complications, 
which are presented by some other researchers in this 
filed are, intraventricular, intracerebral, or subdural 
hemorrhage, hypothalamic injury, CSF leak, basilar 
artery injury, CNS infection, subdural hygroma or 
hematoma, headache due to sub dural air collection 
over the frontal cortex, and epilepsy, having a 
complication rate with the frequency of 8.5%.12 
 The aim of the current study was to address the 
ETV in obstructive hydrocephalus patients in terms of 
determining the pattern and frequency of the 
complications as well as the outcome of the procedure. 
Furthermore, to assess the improvement in the level of 
care for patient of obstructive hydrocephalus. 
 
MATERIAL AND METHODS 
Study Design 
This descriptive study was carried out at the 
Neurosurgery department of Lady Reading Hospital, 
Peshawar and private clinics over a period of 1 year 
(March 2016 to February 2017). Ethical approval was 
sought out before starting the study, through hospitals 
research and ethical committee under reference 
number 406/LRH. Those patients who fulfilled the 
inclusion criteria were included in the study through 
emergency or outpatient and were admitted to the 
neurosurgery ward for further workup. The purpose 
and benefits of this study were made clear to the 
patients in the language they understood and a written 
informed consent was obtained. 
 
Sample Size 
Our sample size was 160 cases with 95% confidence 
interval, 4.4% margin of error and 8.8% proportion of 
complication rate using World Health Organization 
(WHO) sample size calculations.12 The consecutive 
non probability sampling technique was used. 
 
Inclusion Criteria 
The inclusion criteria encompassed all the patients 
with obstructive hydrocephalous and patients of either 
sex with the age range of 6 months to 60 years. 
 
Exclusion Criteria 
While, patients with lesion near a basilar artery or in 
the third ventricular floor, and patients with third 
ventricular size less than seven millimeters, diagnosed 




Detailed history, examination and baseline 
investigations, including imaging; such as CT Scan in 
all patients, while MRI brain in those patients, who 
could afford were done. All the demographics were 
recorded on a predesigned proforma including name, 
age, gender and address. The authenticity of the 
exclusion criteria was maintained to rule out any bias. 
All the study participants were put on next available 
OR list, after optimization for the general anesthesia. 
 
Surgeries 
On next available elective list surgery was performed 
by a single Neurosurgeon with minimum of five years 
of post-fellowship experience. The patients were then 
followed up till 7 days’ post operatively, for CSF leak, 
wound infection, meningitis, seizures, bleeding and in 
hospital death. Wound swab and CT scanBrain were 
carried out for the management of these complications. 
 
Data Analysis 
SPSS version 22 was used for data analysis, which 
was collected on pre-designed forms. For quantitative 
variables like age, mean ± SD was calculated. While, 
for categorical variables like gender, overall 
complications and pattern of complications (CSF leak,
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wound infection, meningitis, 
seizures, bleeding and in hospital 
death), frequencies and 
percentages were calculated. 
Stratification was done for 
complications and pattern of 
complications among gender and 
age to see the effect modification 
using chi square test with p value 
of ≤ 0.05 kept at significant. 
 
RESULTS 
Age and Gender Distribution: 
Age distribution among 160 
patients shows, 72% patients 
(n = 115) were < 5 years of age, 
10% (n = 16) were 6 – 15 years 
of age, 7% (n = 11) were 16 – 25 
years of age, 6% (n = 10) were 
26 – 35 years of age and 5% (n = 
8) were 36 – 45 years of age. 
Mean age was 4 ± 2.16 years. 
 Gender distribution among 
160 patients showed that 56% 
patients (n = 90) were male and 
44% (n = 70) were female. 
Complications: 
 Frequency of complication 
among 160 patients was 
analyzed as, 24 (15%) patients 
had complications while, 136 
(85%) patients did not have any 
complications. 
 
Table 1: Stratification of Patterns of Complications with respect to Age 





6 – 15 
Years 
16 – 25 
Years 
26 – 35 
Years 




Yes 3 2 1 1 1 8 
0.2731 
No 112 14 10 9 7 152 
Total  115 16 11 10 8 160  
Wound 
Infection 
Yes 3 1 1 0 0 5 
0.6461 
No 112 15 10 10 8 155 
Total  115 16 11 10 8 160  
Meningitis 
Yes 3 0 0 0 0 3 
0.8787 
No 112 16 11 10 8 157 
Total  115 16 11 10 8 160  
Seizures 
Yes 3 0 0 0 0 3 
0.8787 
No 112 16 11 10 8 157 
Total  115 16 11 10 8 160  
Bleeding 
Yes 3 0 0 0 0 3 
0.8787 
No 112 16 11 10 8 157 
Total  115 16 11 10 8 160  
In Hospital 
Death 
Yes 2 0 0 0 0 2 
0.9394 
No 113 16 11 10 8 158 
Total  115 16 11 10 8 160  
 
 Patterns of complications among 160 patients 
showed that, 5% patients (n = 8) had CSF leak, 3% 
(n = 5) had wound infection, 2% (n = 3) Meningitis, 
2% (n = 3) seizures, 2% (n = 3) had minor bleeding 
while 1% (n = 2) had in hospital death. 
 Stratification of complication and their patterns 
with age and gender is shown in Table 1 and Table 2 
respectively. 
 
Table 2: Stratification of Patterns of Complications with 
respect to Gender Distribution (n = 160). 
 
Complications Male Female Total P value 
CSF Leak 
Yes 4 4 8 
0.7147 
No 86 66 152 
Total  90 70 160  
Wound 
Infection 
Yes 2 3 5 
0.4568 
No 88 67 155 
Total  90 70 160  
Meningitis 
Yes 2 1 3 
0.7135 
No 88 69 157 
Total  90 70 160  
Seizures 
Yes 2 1 3 
0.7135 
No 88 69 157 
Total  90 70 160  
Bleeding 
Yes 2 1 3 
0.7135 
No 88 69 157 
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Total  90 70 160  
In Hospital 
Death 
Yes 1 1 2 
0.8577 
No 89 69 158 
Total  90 70 160  
 
DISCUSSION 
Hydrocephalus is widespread problem having 
approximately 1 – 1.5% prevalence. Management 
protocols included diversion, either intracranial or 
extracranial.14 In the past few decades, much progress 
has been made in shunt technology, but the treatment 
of hydrocephalus still remains a challenge which has 
led the neurosurgeons for alternate options. 
 Our study showed that the majority of patients 
(72%) were under 5 years of age. The mean age of our 
patients was 4 ± 2.16 years. Among all the patients, 
56% were male and 44% female. Overall, 24 (15%) 
patients had complications in which 5% patients had 
CSF leak, 3% wound infection, 2% meningitis, 
seizures and bleeding each, and 1% patient had in 
hospital death. 
 In literature the complication rate of ETV ranges 
between 2 – 15%, but in few studies it reaches as high 
as 30%. The complication rate of our study is 
compatible with the literature.11,12 
 The reported frequencies of CSF leak after ETV 
for obstructive hydrocephalus include 1.8%, 5.16% 
and 10.2%.13,15,16 In our study, the rate of CSF leak 
was 5% (8 patients). Out of those 8 patients, 7 
recovered with conservative treatment in the form of 
spinal tap, while 1 patient developed meningitis, who 
also recovered subsequently after a period of 3 weeks, 
with conservative treatment. 
 Three percent (n = 5) of our patients developed 
wound infection. All of these were treated with broad 
spectrum antibiotic at first, 2 of them responded. In 
one patient, it did not work, so swab was sent and later 
put on swab C/S specific antibiotic and patient 
improved. In the literature wound infection is reported 
to be 1.8%16 and 6.25%17. 
 Meningitis, seizures and bleeding was seen in 2% 
each in our study. Meningitis was treated 
conservatively and later on patients improved. One 
patient who developed post-operative seizures, expired 
despite of maximum doses of anti-epileptics and other 
supportive treatment, while the rest were improved 
with medications. The bleeding occurred in 2% of our 
patients that was pre-operative and settled down with 
continuous irrigation during the procedure. In one 
patient the small bleeding vessel was also cauterized. 
These complications were also somewhat comparable 
with the literature.12,13,15-16. 
 The mentioned mortality rate after ETV in the 
literature is ranges from 0.22%17 to 10.3%18. In our 
study it was 1% (2 patients). As mentioned earlier, one 
patient died because of seizures, while other due to 
bad chest. 
 Endoscopic third ventriculostomy is contemplated 
as a first line treatment modality for curing obstructive 
hydrocephalus. Because of its less invasive nature, it is 
a preferred treatment option. Moreover, ETV also 
evades the drawbacks associated with shunt 
implantation. In our opinion, ETV is a safe and 




This study was carried out in Peshawar so patients 
from that particular area were enrolled in this study. 
The results of this study could not be generalized to 
the entire Pakistani population. 
 
CONCLUSION 
Our results demonstrated that Endoscopic third 
ventriculostomy can be considered as a treatment 
modality of choice for obstructive hydrocephalus. 
Post-operative complications were minimal with only 
1% mortality rate in our series. We concluded that 
proposed study unlocks a novel opportunity in that 
respect that ETV is a successful treatment for treating 
obstructive hydrocephalus. ETV, if executed properly, 
can be a potentially simple, effective and safe 




1. Grunert P, Charalampaki P, Hopf N, Filippi R. The role 
of third ventriculostomy in the management of 
obstructive hydrocephalus. Min-Minimally Invasive 
Neurosurgery, 2003; 46 (01): 16-21. 
2. Aschoff A, Kremer P, Hashemi B, Kunze S. The 
scientific history of hydrocephalus and its treatment. 
Neurosurg Rev. 1999; 22 (2-3): 67-93. 
3. Bayston R. Hydrocephalus shunt infections. J 
Antimicrob Chemother. 1994; 34 (suppl_A): 75-84. 
4. Dandy W. An operative procedure for hydrocephalus. 
Bull Johns Hopkins Hosp. 1922; 33: 189-90. 
5. Scarff JE. Treatment of obstructive hydrocephalus by 
Muhammad Anwar Ullah, et al 
-241-         Pak. J. of Neurol. Surg. – Vol. 24, No. 3, Jul. – Sep., 2020         http//www.pakjns.org 
puncture of the lamina terminalis and floor of the third 
ventricle. J Neurosurg. 1951; 8 (2): 204-13. 
6. Mixter W. Ventriculoscopy and puncture of the floor of 
the third ventricle: preliminary report of a case. Bost. 
Med. & Surg. J. 1923; 188 (9): 277-8. 
7. Hirsch J-F. Percutaneous ventriculocisternostomies in 
non-communicating hydrocephalus.  Shunts and 
Problems in Shunts: Karger Publishers; 1982: p. 170-8. 
8. Jones RF, Kwok BC, Stening WA, Vonau M. The 
current status of endoscopic third ventriculostomy in 
the management of non-communicating hydrocephalus. 
Minim Invas Neurosur. 1994; 37 (01): 28-36. 
9. Greenberg M. Handbook of Neurosurgery. 6-th ed. 
New York, 2006: 289-365. 
10. Kulkarni AV, Riva-Cambrin J, Browd SR. Use of the 
ETV Success Score to explain the variation in reported 
endoscopic third ventriculostomy success rates among 
published case series of childhood hydrocephalus. J 
Neurosurg Ped. 2011; 7 (2): 143-6. 
11. Yadav YR, Parihar V, Pande S, Namdev H, Agarwal 
M. Endoscopic third ventriculostomy. J Neurosci Rural 
Pract. 2012; 3 (2): 163. 
12. Sokal P, Birski M, Rusinek M, Paczkowski D, Zieliński 
P, Harat A. Endoscopic third ventriculostomy in 
treatment of hydrocephalus. Videosurg Other 
Miniinvasive Tech. 2012; 7 (4): 280. 
13. Yadav YR, Parihar V, Agrawal M, Bhatele PR. 
Endoscopic third ventriculostomy in tubercular 
meningitis with hydrocephalus. Neurology India, 2011; 
59 (6): 855. 
14. Brohi SR, Brohi AR, Sidiqui MA, Mughal SA, Saeed 
S. Outcome of endoscopic third ventriculostomy in 
hydrocephalus. J Surg Pak. 2010; 15 (1): 25-8. 
15. Ali M, Usman M, Khan Z, Khan KM, Hussain R, 
Khanzada K. Endoscopic third ventriculostomy for 
obstructive hydrocephalus. J Coll Physicians Surg Pak. 
2013; 23 (5): 338-41. 
16. Mohanty A, Santosh V, Devi BI, Satish S, Biswas A. 
Efficacy of simultaneous single-trajectory endoscopic 
tumor biopsy and endoscopic cerebrospinal fluid 
diversion procedures in intra-and paraventricular 
tumors. Neurosurg Focus, 2011; 30 (4): E4. 
17. Chen CC, Kasper E and Warnke P. Palliative 
stereotactic-endoscopic third ventriculostomy for the 
treatment of obstructive hydrocephalus from cerebral 
metastasis. Surg Neurol Int. 2011; 2: 76. 
18. Feng H, Huang G, Liao X, Fu K, Tan H, Pu H, et al. 
Endoscopic third ventriculostomy in the management of 
obstructive hydrocephalus: an outcome analysis. J 







Disclosures:  Authors report no conflict of interest. 
Ethical Review Board Approval:  The study was conformed to the ethical review board requirements. 
Human Subjects:  Consent was obtained by all patients/participants in this study. 
Conflicts of Interest: 
In compliance with the ICMJE uniform disclosure form, all authors declare the following: 
Financial Relationships:  All authors have declared that they have no financial relationships at present or within the 
previous three years with any organizations that might have an interest in the submitted work. 
Other Relationships:  All authors have declared that there are no other relationships or activities that could appear to have 




Address for Correspondence: 
Dr. Muhammad Usman 











Frequency and Pattern of Early Complications after Endoscopic Third Ventriculostomy in Obstructive 
http//www.pakjns.org         Pak. J. of Neurol. Surg. – Vol. 24, No. 3, Jul. – Sep., 2020         -242- 
AUTHORS CONTRIBUTIONS 
 
Sr.# Author’s Full Name Intellectual Contribution to Paper in Terms of: 
1. Muhammad Anwar Ullah 
Conception and study design, data collection, drafting, final approval of the version 
to be published. 
2. Fahim Ullah Khan Literature search, critical review, final approval of the version to be published. 
3. Muhammad Usman 
Drafting, Data analysis, Critical review, final approval of the version to be 
published. 
4. Mohammad Ishaq Data interpretation, Data analysis, final approval of the version to be published. 




Date of Submission: 01-06-2020 
Date of Revision: 01-7-2020 
Date of Online Publishing: 25-09-2020 
Date of Print: 30-09-2020 
 
 
 
